Case File
efta-efta00642623DOJ Data Set 9OtherFrom: "Morits Skaugen"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00642623
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Morits Skaugen"
To: "Jeffrey Epstein" <[email protected]>
Subject: RE: test
Date: Tue, 15 Feb 2011 12:57:43 +0000
Sent following to Terje today:
Terje
Pls check US taxation re below that i discussed with JE by phone..
My idea is that i incorporate a company (SPV) for this in norway.
I call this "FT5 AS"
This company will be owned by my personal investment company.
I will pay in equity to establish the company.
The "FT5AS" will buy the house for say NOK 18 mill.
This is partly financed by your equity from sale of the apartment (how much?) and partly from loans secured by
JE — the balance.
The loans from JE can be secured against a 1 priority Mortgage in the house. The terms of the loan needs to be
discussed. The profile of the lender need not to be known by anyone.
The 1 PM can be issued in favor of a lawyer in Norway also to cover for JE.
You will rent the house and pay a small rent for tax reasons.
The rent should cover property taxes and water and utilities etc and whatever is needed for JE loan to be
serviced.
The company will not make a profit this way and that is ok with me.
You will have a right to purchase the shares of the FT5AS at any time at my cost - and the house at any time to
reflect this.
Agreements to secure this will be entered into to give you security.
These can be deposited with a legal person that you trust.
Best personal regards,
Moths
From: Jeffrey Epstein [[email protected]]
Sent: 14. februar 2011 15:43
To: Malts Skaugen
Subject: Re: test
great
On Mon, Feb 14, 2011 at 9:37 AM, Morits Skaugen
wrote:
Best personal regards,
Morits Skaugen
CEO
EFTA00642623
Error! Filename not specified. I.M. Skaugen SE
IMS - Innovative Maritime Solutions
www.skaugen.com
*******
****************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00642624
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.